Karyopharm Therapeutics | KPTI - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 364.22B 20.46B 2026-05
Abbott USD 178.41B 39.46B 2026-03
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 21.73B 3B 2026-05
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
MacroGenics USD 102M 4M 2025-12
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Takeda JPY 8.33T 681.01B 2026-05
Tectonic Therapeutic USD 390M 96M 2025-12
TG Therapeutics USD 6.48B 1.18B 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Xencor USD 795M 98M 2026-05